HBSP (USA)
-
Strategies to Fight Low-Cost Rivals (Spanish version)
Kumar, NirmalyaArticle HBS-R0612FStrategySlashing prices usually lowers profits for incumbents without driving the low-cost entrants out of business. Companies take various approaches to competing against cut-price players. Some differentiate their products--a strategy that works only in certain circumstances. Others launch low-cost businesses of their own, as many airlines did in the 1990s--a so-called dual strategy that succeeds only if companies can generate synergies between the ex...Starting at €8.20
-
How Emerging Giants Are Rewriting the Rules of M&A (Spanish version)
Kumar, NirmalyaArticle HBS-R0905KStrategyThis article includes a one-page preview that quickly summarizes the key ideas and provides an overview of how the concepts work in practice along with suggestions for further reading. While Western companies struggle with mergers and acquisitions, emerging giants like Indian aluminum producer Hindalco are using M&A as their main globalization strategy. That's partly because developing economies grew at near double-digit rates in the past 15 year...Starting at €8.20
-
Don't Be Undersold!
Steenkamp, Jan-Benedict E.M.; Kumar, NirmalyaArticle HBS-R0912K-EMarketing"Aldi" is a word that strikes fear in the hearts of brand managers across Europe. A chain of low-budget retail stores with sales of $73.5 billion in 2008, Aldi invented what is commonly referred to as the hard-discount store, a format that is destroying between a quarter and a half trillion dollars in brand sales annually. Brand executives at major consumer packaged goods companies have mostly been caught off guard by this success. The authors' r...Starting at €8.20
-
No se excluya del superdescuento!
Steenkamp, Jan-Benedict E.M.; Kumar, NirmalyaArticle HBS-R0912KMarketingAldi es una palabra que provoca temor en los corazones de los gerentes de marca en toda Europa. Una cadena de tiendas al por menor de bajo presupuesto con ventas de $ 73,5 mil millones en 2008, Aldi inventó lo que se conoce comúnmente como la tienda de descuento duro, un formato que está destruyendo entre un cuarto y medio billón de dólares en ventas de la marca anualmente. ejecutivos de la marca en las principales compañías de bienes de consumo ...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCase HBS-618025-EService and Operations ManagementIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Starting at €8.20
-
Twine Health, Teaching Note
Huckman, Robert S.; Stern, Ariel D.Teaching Note HBS-618055-EService and Operations ManagementTeaching note for case 615068.Starting at €0.00
-
Maven Clinic: Women's Health in the Digital Age
Stern, Ariel D.; Mehta, SarahCase HBS-620035-EStrategyIn late 2017, Kate Ryder, the founder and CEO of digital women's health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners across a range of services and specialties for a fee, and an enterprise product-the Maven Family Benefits platform-which it sold to large employers as an employee benefit. Since found...Starting at €8.20
-
Twine Health
Huckman, Robert S.; Stern, Ariel D.; Preble, MatthewCase HBS-615068-EService and Operations ManagementIn late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that enabled patients to create and manage chronic disease treatment plans in conjunction with their primary care providers and specialized coaches. Twine had already enjoyed impressive succes...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future, Teaching Note
Stern, Ariel D.; Mehta, SarahTeaching Note HBS-618048-EEntrepreneurshipThis teaching note provides guidance and recommendations for teaching HBS Case No. 618025, entitled "Adaptive Platform Trials: The Clinical Trial of the Future?"Starting at €0.00
-
Adaptive Platform Trials: The Clinical Trial of the Future (B)
Stern, Ariel D.; Mehta, SarahCase HBS-620001-EEntrepreneurshipThis case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander's efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is c...Starting at €5.74